Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; Phase II trial

  • Howard S. Hochster
  • , Michael D. Green
  • , Ronald H. Blum
  • , James C. Wernz
  • , James L. Speyer
  • , Franco M. Muggia

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; Phase II trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science